Latest filing published 14 Jun 2024 for Aerovate Therapeutics, Inc., €30k. Read the official filing
George A. Eldridge discloses dealings in Jade Biosciences, Inc. to SEC (Form 4). The record holds 20 filings, for trades running from 18 November 2022 to 14 June 2024.
Every open-market trade on record is a sale: 7 sales worth €397k. Besides market trades, the filings include 13 option exercises.
The latest filing, published on 14 June 2024, reports an option exercise of €30k in Jade Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations